This study is the first to propose that AKR1A1-mediated lactylation is closely linked to metabolic reprogramming, thereby constructing a tripartite regulatory framework of “lactylation–metabolism–immunity” and offering a novel perspective on the metabolic pathology of osteoporosis. This evidence concerns the gene AKR1A1 and osteoporosis.